L'Institut Bergonié est un établissement de santé privé d'intérêt collectif depuis le 20 mai 2010 et également l'un des 18 centres régionaux de lutte contre le cancer. Il est situé sur la commune de Bordeaux dans le département de la Gironde en région Nouvelle-Aquitaine.

During the past decade, Institut Bergonie; Oncologie conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Bergonie; Oncologie" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Institut Bergonie; Oncologie" are "Breast Cancer" (7 trials), "Ovarian Cancer" (4 trials), "Solid Tumors" (2 trials), "Adult Solid Tumor" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Institut Bergonie; Oncologie" in a lesser frequency.

Most popular intervention types in "Institut Bergonie; Oncologie" are "Drug" (22 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (9 trials), "Atezolizumab" (4 trials), "Bevacizumab" (4 trials), "Carboplatin" (4 trials) and "Cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Institut Bergonie; Oncologie" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Institut Bergonie; Oncologie". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Institut Bergonie; Oncologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Bergonie; Oncologie, 5 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".